Name | 1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide |
---|---|
Synonyms |
1-(2,4-Dichlorophenyl)-5-(4-methoxyphenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide
Roxindole hydrochloride |
Description | NIDA-41020 is a potent and selective cannabinoid receptor 1(CB1) antagonist with a Ki of 4.1 nM. NIDA-41020 was designed as a potential radioligand for use in positron emission tomography (PET)[1]. |
---|---|
Related Catalog | |
Target |
CB1:4.1 nM (Ki) |
References |
Molecular Formula | C23H24Cl2N4O2 |
---|---|
Molecular Weight | 459.36800 |
Exact Mass | 458.12800 |
PSA | 59.39000 |
LogP | 5.62260 |
Storage condition | 2-8°C |
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H300-H315-H319-H335 |
Precautionary Statements | P261-P264-P301 + P310-P305 + P351 + P338 |
Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
Risk Phrases | 25-36/37/38 |
Safety Phrases | 26-45 |
RIDADR | UN 2811 6.1 / PGIII |